Health-related quality of life after radical prostatectomy and low-dose-rate brachytherapy for localized prostate cancer

Urologia Internationalis

Volumn 82, Issue 1, 2009, Pages 17-23

  Wyler, Stephen Frederic ^a,c   Engeler, Daniel Stephan ^a   Seelentag, Wolfhart ^b   Ries, Gerhard ^b   Schmid, Hans Peter ^a  

^a Kantonsspital St Gallen Klinik fur Urologie   (Switzerland)

^b University Hospital Basel ^*  (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Brachytherapy; Prostate cancer; Quality of life; Radical prostatectomy

Indexed keywords

GONADORELIN DERIVATIVE;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; DIARRHEA; FOLLOW UP; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; RADIATION DOSE;

AGED; BRACHYTHERAPY; DATABASES AS TOPIC; DIARRHEA; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; RADIATION DOSAGE; SWITZERLAND; TIME FACTORS; TREATMENT OUTCOME;

EID: 58849125709     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000176019     Document Type: Article

References (17)

1. Aus G, Abbou CC, Bolla M, Heidenreich A, Schmid HP, van Poppel H, Wolff J, Zattoni F: EAU guidelines on prostate cancer. Eur Urol 2005;48:546-551.
2. Penson DF, Litwin MS, Aaronson NK: Health related quality of life in men with prostate cancer. J Urol 2003;169:1653-1661.
3. Helgason AR, Adolfsson J, Dickman P, Fredrikson M, Arver S, Steineck G: Waning sexual function: the most important disease-specific distress for patients with prostate cancer. Br J Cancer 1996;73:1417-1421.
4. Gwede CK, Pow-Sang J, Seigne J, Heysek R, Helal M, Shade K, Cantor A, Jacobsen PB: Treatment decision-making strategies and influences in patients with localized prostate carcinoma. Cancer 2005;104:1381-1390.
5. Walsh PC: Anatomic radical prostatectomy: evolution of the surgical technique. J Urol 1998;160:2418-2424.
6. Nag S, Beyer D, Friedland J, Grimm P, Nath R: American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys 1999;44:789-799.
7. Hall JD, Boyd JC, Lippert MC, Theodorescu D: Why patients choose prostatectomy or brachytherapy for localized prostate cancer: results of a descriptive survey. Urology 2003;61:402-407.
8. Borchers H, Kirschner-Hermanns R, Brehmer B, Tietze L, Reineke T, Pinkawa M, Eble MJ, Jakse G: Permanent 125I-seed brachytherapy or radical prostatectomy: a prospective comparison considering oncological and quality of life results. BJU Int 2004;94:805-811.
9. Krupski T, Petroni GR, Bissonette EA, Theodorescu D: Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer. Urology 2000;55:736-742.
10. Lee WR, Hall MC, McQuellon RP, Case LD, McCullough DL: A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy. Int J Radiat Oncol Biol Phys 2001;51:614-623.
11. Davis JW, Kuban DA, Lynch DF, Schellhammer PF: Quality of life after treatment for localized prostate cancer: differences based on treatment modality. J Urol 2001;166:947-952.
12. Bacon CG, Giovannucci E, Testa M, Kawachi I: The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer. J Urol 2001;166:1804-1810.
13. Wei JT, Dunn RL, Sandler HM, McLaughlin PW, Montie JE, Litwin MS, Nyquist L, Sanda MG: Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol 2002;20:557-566.
14. Bradley EB, Bissonette EA, Theodorescu D: Determinants of long-term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer. BJU Int 2004;94:1003-1009.
15. Downs TM, Sadetsky N, Pasta DJ, Grossfeld GD, Kane CJ, Mehta SS, Carroll PR, Lubeck DP: Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer: data from CaPSURE. J Urol 2003;170:1822-1827.
16. Miller DC, Sanda MG, Dunn RL, Montie JE, Pimentel H, Sandler HM, Mc Laughlin JP, Wei JT: Long-term outcomes among localized prostate cancer survivors: healthrelated quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol 2005;23:2772-2780.
17. Fulmer BR, Bissonette EA, Petroni GR, Theodorescu D: Prospective assessment of voiding and sexual function after treatment for localized prostate carcinoma: comparison of radical prostatectomy to hormonobrachytherapy with and without external beam radiotherapy. Cancer 2001;91:2046-2055.